NewsDialy
The CEO of Reproductive Futures stated that FDA commissioner nominee Heidi Overton is ignoring scientific evidence regarding mifepristone, a key abortion medication.
Overton appeared before the Senate health committee on Thursday to answer questions about her views on the drug.
The CEO of the legal organization, which advocates for reproductive rights, expressed deep concern after Overton avoided directly addressing the issue.
The statement argues that Overton’s anti-abortion stance is evident and warns that she could use her position as FDA commissioner to implement views that cause serious harm.
Keep reading